Delivery Order SPE2DB22D2103-SPE2DB24FR9BW
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $8,543.70 firm fixed price delivery order is for the provision of Focalin XR 10 mg capsules. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,847.03, is for the supply of Focalin XR 10 mg capsules in 100-count bottles. The contract has a firm fixed price structure and an ultimate completion date of March 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,511.61 firm fixed price delivery order is for the supply of Focalin XR 15 mg capsules with a completion date of February 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Focalin XR 30 mg capsules to support the Medical Supply Chain of the Defense Logistics Agency (DLA). The $5,105.72 firm-fixed-price delivery order has a completion date of September 12, 2024 and is not set aside for any particular business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $6,420.65, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of Focalin XR capsules (10mg). The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to support various government agencies and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $4,938.36, is a firm fixed price delivery order for 4,563,939,307 units of the pharmaceutical product Focalin XR 25 mg capsules, to be delivered by March 13, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,978.39 firm-fixed-price delivery order is for the supply of Focalin XR 20 mg capsules, with a completion date of August 13, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Focalin XR 5 mg capsules. The $1,681.94 Firm Fixed Price contract has a completion date of September 5, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Focalin XR 10 mg capsules. The $1,176.66 firm fixed-price delivery order has a completion date of November 6, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,331.70 firm fixed-price delivery order is for Focalin XR 5 mg capsules, with a completion date of May 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR9BWDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $5,600.45, is for the delivery of Focalin XR 40 mg capsules to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC does not have any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 3/22/24 |